Preparation of a Nanoemulsion Adjuvant Vaccine

Published: May 31, 2024

Abstract

Source: Zhang, Z. et al., Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo. J. Vis. Exp. (2022)

This video demonstrates the production of nanoemulsion tumor vaccines. The stable oil reservoir depots carrying synthetic peptides and adjuvants are produced by low-energy nanoemulsion, offering significant promise for tumor immunotherapy.

Protocol

1. Preparation of the I-OVA NE Admix 1 mg of monophosphoryl lipid A (MPLA) with 100 µL of dimethyl sulfoxide (DMSO), vortex for 5 min, and allow it to stand for 4 h at room temperature (RT) to dissolve completely. Add Tween 80 and IKVAV-OVA257-264 (I-OVA) quantitatively and mix.          NOTE: Tween 80 and I-OVA were mixed at a mass ratio of 25:1. Add squalene into the mixture prepared in …

Offenlegungen

The authors have nothing to disclose.

Materials

MPLA Invivogen
Lit. Co.
tlrl-mpla
OVA257–264 Shanghai Botai
Biotechnology Co., Ltd.
NA
Synthetic peptide (I-OVA) conjugation of IKVAV-PA Shanghai Botai
Biotechnology Co., Ltd.
NA

Tags

This article has been published
Video Coming Soon
Keep me updated:

.

Diesen Artikel zitieren
Preparation of a Nanoemulsion Adjuvant Vaccine. J. Vis. Exp. (Pending Publication), e22245, doi: (2024).

View Video